✦ LIBER ✦
A phase I/IIa study of the mRNA based cancer vaccine CV9103 prepared with the RNActive technology results in distinctly longer survival than predicted by the Halabi Nomogram which correlates with the induction of antigen-specific immune responses
✍ Scribed by Karl-Josef Kallen,Ulrike Gnad-Vogt,Birgit Scheel…
- Book ID
- 126381255
- Publisher
- Springer (Biomed Central Ltd.)
- Year
- 2013
- Tongue
- English
- Weight
- 63 KB
- Volume
- 1
- Category
- Article
- ISSN
- 2051-1426
No coin nor oath required. For personal study only.